Qiagen NV (QGEN)
41.52
-0.37
(-0.88%)
USD |
NYSE |
Apr 24, 16:00
41.53
+0.01
(+0.02%)
After-Hours: 20:00
Qiagen Revenue (TTM)
Revenue (TTM) Chart
Historical Revenue (TTM) Data
| Date | Value |
|---|---|
| December 31, 2022 | 2.142B |
| September 30, 2022 | 2.226B |
| June 30, 2022 | 2.261B |
| March 31, 2022 | 2.313B |
| December 31, 2021 | 2.252B |
| September 30, 2021 | 2.240B |
| June 30, 2021 | 2.190B |
| March 31, 2021 | 2.065B |
| December 31, 2020 | 1.870B |
| September 30, 2020 | 1.713B |
| June 30, 2020 | 1.612B |
| March 31, 2020 | 1.550B |
| December 31, 2019 | 1.526B |
| September 30, 2019 | 1.516B |
| June 30, 2019 | 1.511B |
| March 31, 2019 | 1.507B |
| December 31, 2018 | 1.502B |
| September 30, 2018 | 1.496B |
| June 30, 2018 | 1.482B |
| March 31, 2018 | 1.453B |
| December 31, 2017 | 1.418B |
| September 30, 2017 | 1.387B |
| June 30, 2017 | 1.362B |
| March 31, 2017 | 1.347B |
| December 31, 2016 | 1.338B |
| Date | Value |
|---|---|
| September 30, 2016 | 1.320B |
| June 30, 2016 | 1.296B |
| March 31, 2016 | 1.281B |
| December 31, 2015 | 1.281B |
| September 30, 2015 | 1.293B |
| June 30, 2015 | 1.315B |
| March 31, 2015 | 1.326B |
| December 31, 2014 | 1.345B |
| September 30, 2014 | 1.345B |
| June 30, 2014 | 1.331B |
| March 31, 2014 | 1.315B |
| December 31, 2013 | 1.302B |
| September 30, 2013 | 1.287B |
| June 30, 2013 | 1.270B |
| March 31, 2013 | 1.262B |
| December 31, 2012 | 1.254B |
| September 30, 2012 | 1.242B |
| June 30, 2012 | 1.227B |
| March 31, 2012 | 1.202B |
| December 31, 2011 | 1.170B |
| September 30, 2011 | 1.121B |
| June 30, 2011 | 1.107B |
| March 31, 2011 | 1.087B |
| December 31, 2010 | 1.087B |
| September 30, 2010 | 1.090B |
Revenues Definition
Revenues measure the total amount of value that a company brings in during a certain period. This is also considered the "top-line" of the income statement. Revenues are used for all operating expenses as well as other line items which eventually lead to the net income for the company. Revenue is an extremely important metric when analyzing a company. A company with efficient margins is able to turn revenues into the most net income.
Revenue (TTM) Range, Past 5 Years
1.511B
Minimum
Jun 2019
2.313B
Maximum
Mar 2022
1.932B
Average
2.065B
Median
Mar 2021
Revenue (TTM) Benchmarks
| MoonLake Immunotherapeutics | -- |
| LENZ Therapeutics Inc | -- |
| Thermo Fisher Scientific Inc | 42.86B |
| uniQure NV | 15.84M |
| ProQR Therapeutics NV | 7.046M |